UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 30, 1998
--------------------------
TOTAL RENAL CARE HOLDINGS, INC.
- ---------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-4034 51-0354549
- ---------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
21250 Hawthorne Boulevard, Suite 800, Torrance, California 90503
- ---------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrants' telephone number, including area code (310) 792-2600
------------------------
N/A
- ---------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit No. Description
----------- -----------
99.1 Press Release dated April 30, 1998
99.2 Press Release dated April 30, 1998
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Total Renal Care Holdings, Inc.
---------------------------------
(Registrant)
Date April 30, 1998 /s/ John E. King
------------------------ ---------------------------------
(Signature)*
John E. King
Vice President, Finance and Chief
Financial Officer
*Print name and title of the signing officer under his signature.